K770316

Substantially Equivalent

ALKALINE PHOSPHATASE ENZYMATIC

Applicant: Icn Pharmaceuticals, Inc.
Product code: CJE
Advisory panel: Clinical Chemistry
Date received: 1977-02-16
Decision date: 1977-03-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Orangeburg, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.